3 Recruiting Advanced Urothelial Carcinoma Phase 1 Clinical Trials

Active phase 1 studies for advanced urothelial carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Advanced Urothelial Carcinoma studies

Phase 1 Studies for Advanced Urothelial Carcinoma

🔵 Active, Not Recruiting Phase1

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

📍 Tower Cancer Research Foundation — Beverly Hills, California

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase1 / Phase2

Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer

📍 VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut

View Study & Checklist ➔